FTC Funeral Rule requirements remain in place, but expectations around pricing transparency are evolving. This article explores compliance risks, real-world conversations, and how funeral homes can adapt in 2026.

What samples are needed for post-mortem DNA testing? This guide explains which biological samples provide the best results, how storage affects DNA quality, and what options may still be available over time.

Tumor biomarkers play a critical role in shaping treatment strategy and clinical decision-making. This article explains how pathology data informs personalized care, risk assessment, and treatment selection in modern life sciences.